From April 1, 2024 to June 30, 2024, the company has repurchased 2,000,000 shares, representing 0.5% for CNY 31.19 million. With this, the company has completed the repurchase of 2,000,000 shares, representing 0.5% for CNY 31.19 million under the buyback announced on March 16, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.49 CNY | +0.67% |
|
-0.52% | -48.08% |
1st Jan change | Capi. | |
---|---|---|
-48.08% | 744M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- 301246 Stock
- News Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
- Tranche Update on Hubei Hongyuan Pharmaceutical Technology Co., Ltd.'s Equity Buyback Plan announced on March 16, 2024.